AI summary · may contain errors
Baveno VIII consensus updated guidance for advanced chronic liver disease and portal hypertension, with 272 statements and recommendations reaching strong consensus (>80% agreement).
- 1 cited this week
- Open access
Elsevier BV · Gastroenterology & Hepatology · ISSN 0168-8278, 1600-0641
Rebuilt
AI summary · may contain errors
Baveno VIII consensus updated guidance for advanced chronic liver disease and portal hypertension, with 272 statements and recommendations reaching strong consensus (>80% agreement).
AI summary · may contain errors
A modified Delphi consensus in primary biliary cholangitis (PBC) reached agreement on 16 statements and 42 recommendations, with 62 international panelists and 88% then 60% voting response rates.
AI summary · may contain errors
In compensated chronic hepatitis D, bulevirtide monotherapy for 144 weeks produced end-of-treatment virologic response rates of 73% (2 mg), 76% (10 mg), and 92% (DT/10), with post-treatment decline.
AI summary · may contain errors
In adults with cirrhosis at high risk for hepatocellular carcinoma, HelioLiver Dx detected 47.8% of HCC lesions overall and 28.6% of lesions ≤2 cm.
Newest first · last 60 days
AI summary · may contain errors
Aquitalea magnusonii translocation across the intestinal barrier is linked to systemic inflammation and liver fibrosis in chronic liver disease models, including ACLF-associated metabolite production.
AI summary · may contain errors
Telomere-induced senescence in mouse hepatocytes causes clonal imbalance and blocks hepatocyte-to-ductal metaplasia during chronic liver injury, reshaping regenerative lineages.
AI summary · may contain errors
Seladelpar 10 mg once daily normalized alkaline phosphatase in 75.4% of primary biliary cholangitis patients with ALP 1–1.67×ULN at Month 12 versus 16.1% on placebo.
AI summary · may contain errors
In a 66-year-old man with PI*ZZ SERPINA1 alpha-1 antitrypsin deficiency, liver biopsy 10 weeks after in vivo base editing showed 54–57% correction of the PI*ZZ allele.
AI summary · may contain errors
Anti-CCL2-conjugated platelets (PLT-aCCL2) attenuate early ischemia-reperfusion and orthotopic liver allograft injury by reducing CCR2+ monocyte infiltration after a single intravenous dose.
AI summary · may contain errors
Anserine supplementation restores antibacterial immunity in cirrhotic mice by reconstituting hepatocyte CCL5–mediated recruitment of CD44+ plasmacytoid dendritic cells, reducing bacterial burden and mortality.
AI summary · may contain errors
A pan-elastography machine-learning ELM score predicts clinically significant portal hypertension in compensated advanced chronic liver disease with external AUC 0.91 and reduced the gray zone to 12.3%.
AI summary · may contain errors
Fibrosis regression in chronic liver disease can substantially disappear or be remodelled, and even established cirrhosis reversal has been documented, but clinical significance of regressive histology remains largely unstudied.
AI summary · may contain errors
In a Hong Kong cohort of 294,096 newly diagnosed T2DM patients, higher time-weighted average HbA1c is linked to greater liver-related event risk (aCSHR 1.12 per 1%).
AI summary · may contain errors
Cirrhosis is a dynamic, modifiable disease state in which sustained aetiological control can induce meaningful architectural remodelling, but regression often leaves residual vascular dysfunction and oncogenic risk.
AI summary · may contain errors
Endocrine-disrupting chemicals are linked to MASLD progression by rewiring hepatic nuclear receptor pathways, imprinting overlapping pro-steatotic and pro-inflammatory molecular signatures.
AI summary · may contain errors
MERP-pre and MERP-post MRI-based models predict 1-year very early recurrence after curative resection of single BCLC 0/A hepatocellular carcinoma, with C-index 0.685–0.790 across test cohorts.
AI summary · may contain errors
Recombinant IL-19 protects Il19-deficient mice from acetaminophen-induced liver injury by suppressing proinflammatory macrophage infiltration, linked to reduced S100A8/A9+ macrophage accumulation.
AI summary · may contain errors
Primary refractoriness to atezolizumab plus bevacizumab in hepatocellular carcinoma is linked to markedly worse overall survival (AB-real: 7.3 vs 31.5 months).
AI summary · may contain errors
Baveno VIII consensus updated guidance for advanced chronic liver disease and portal hypertension, with 272 statements and recommendations reaching strong consensus (>80% agreement).
Journals this month
Topics moving, week to 17 Nov 2026
By field